Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.Unknown journal · 2026-06-30Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposasesMetabolic Engineering · 2026-06-13A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-05Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamineGeneral Hospital Psychiatry · 2026-02-24Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy VolunteersResearch Square · 2026-02-11Wherefore the magic? The evolutionary role of psilocybin in naturebioRxiv · 2025-12-18Taking a Trip into Nature’s Medicine Cabinet: A Country Comparison of Efforts to Reschedule Psilocybin and MDMA for Therapeutic UseeYLS (Yale Law School) · 2025-11-30Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Unknown journal · 2025-11-30The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.Journal of psychoactive drugs · 2025-11-08Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.Unknown journal · 2025-10-15Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Unknown journal · 2025-09-06Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybinMolecular Psychiatry · 2025-08-25Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resourcemedRxiv · 2025-08-15Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.Unknown journal · 2025-07-17Mycelium Growth and Development of Psilocybe spp. Mother Cultures on Agar-Based MediaJournal of Fungi · 2025-06-12Pathway engineering for the biosynthesis of psychedelics.Unknown journal · 2025-05-14Race/ethnicity moderates the associations between lifetime psilocybin use and opioid use disorderPLoS ONE · 2025-05-06Psilocybin biosynthesis enhancement through gene source optimizationMetabolic Engineering · 2025-04-1558. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-08Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimizationFrontiers in Psychiatry · 2025-04-07Age- and estrous-dependent effects of psilocybin in ratsbioRxiv · 2025-01-13Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health ConditionsAmerican Journal of Psychiatry · 2024-12-31Short- and long-term reconfiguration of rat prefrontal cortical networks following single doses of psilocybinbioRxiv · 2024-12-12Associations between psychedelic use and cannabis use disorder in a nationally representative sample.Unknown journal · 2024-11-13Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey studyJournal of Affective Disorders · 2024-10-21Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertensionFrontiers in Psychiatry · 2024-06-23Effect of oral tryptamines on the gut microbiome of rats-a preliminary studyPeerJ · 2024-06-02Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushroomsBritish Journal of Pharmacology · 2024-06-01Psilocybin-induced anxiolytic effects supported by transient elevation of corticosteroneJournal of Pharmacology and Experimental Therapeutics · 2024-05-12In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybinFrontiers in Psychiatry · 2024-01-07Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2023-12-31Psychedelic Integration: Psychotherapy for non-ordinary states of consciousnessJournal of Psychedelic Studies · 2023-11-15Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushroomsbioRxiv · 2023-10-22A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.Unknown journal · 2023-08-31Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrestsFrontiers in Psychiatry · 2023-08-23Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Unknown journal · 2023-08-23Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen useAddictive Behaviors Reports · 2023-08-10Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in MiceACS Pharmacology & Translational Science · 2023-08-01Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.Unknown journal · 2023-07-18Confronting the figure of the “mad scientist” in psychedelic history: LSD’s use as a correctional tool in the postwar periodFrontiers in Psychology · 2023-07-12Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialBJPsych Open · 2023-06-30“Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli”Biotechnology and Bioengineering · 2023-06-19Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionPsychological Medicine · 2023-06-01Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sampleScientific Reports · 2023-02-10Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparationJournal of Affective Disorders · 2023-01-24Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescentsScientific Reports · 2022-12-18Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.Journal of Psychopharmacology · 2022-10-30Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.Scientific Reports · 2022-10-09Associations between classic psychedelics and nicotine dependence in a nationally representative sample.Scientific Reports · 2022-06-21Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.Scientific Reports · 2022-04-06Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats.Metabolic Engineering Communications · 2022-03-11Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study.Scientific Reports · 2022-02-15MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.Journal of Psychopharmacology · 2022-01-04Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.Journal of Psychopharmacology · 2022-01-04The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension.Journal of Psychopharmacology · 2021-12-31Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?Bioengineered · 2021-11-30Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02Psilocybin Can Diminish DepressionThe Primary Care Companion For CNS Disorders · 2020-09-01Psychedelics as a Treatment for Alzheimer's Disease Dementia.Unknown journal · 2020-08-20Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid ReleasebioRxiv · 2020-08-13In vivo production of psilocybin in E. coliMetabolic Engineering · 2019-09-20'Magic mushroom' poisoning in a colt.The Veterinary record · 1990-12-14